Harvard Bioscience

company in Holliston, United States

HBIO Nasdaq ISIN US4169061052 SEC CIK 1123494 LEI 549300VLGB1D47GGC642
Follow Harvard Bioscience Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $22.2M +7.8% vs same quarter last year
Net income −$2.6M −113.1% vs same quarter last year
EPS, diluted −$0.58 −107.1% vs same quarter last year
Operating cash flow −$248K −122.9% vs same quarter last year
Revenue by quarter
$24.6M
$21.8M
$20.5M
$20.6M
$23.7M
$20.8M
$22.7M
$22.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100M$150MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$86.6M−$56.7M
FY24$94.1M−$12.4M
FY23$112.3M−$3.4M
FY22$113.3M−$9.5M
FY21$118.9M−$288K
FY20$102.1M−$7.8M
FY19$116.2M−$4.7M
FY18$120.8M−$2.9M
FY17$77.4M−$865K
FY16$104.5M−$4.3M
FY15$108.7M−$19M
FY14$108.7M$2.4M
FY13$105.2M−$1.8M
FY12$111.2M$2.4M
FY11$108.9M$3.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2557.7%−56.1%−65.5%
FY2458.2%−6.6%−13.2%
FY2358.9%1.7%−3%
FY2253.7%−6.1%−8.4%
FY2156.9%1.7%−0.2%
FY2056.8%0.2%−7.6%
FY1955.4%0.3%−4%
FY1852.3%0.8%−2.4%
FY1750.6%−0.8%−1.1%
FY1646.3%−2.9%−4.1%
FY1544.8%−1.6%−17.5%
FY1445.4%6.1%2.2%
FY1345.4%1.5%−1.7%
FY1247.1%7%2.1%
FY1146.1%7.7%3.5%
Free cash flowOperating cash flow minus capital expenditure
−$5M$0$5M$10M$15MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$5.5M
FY24−$1.2M
FY23$12.2M
FY22−$438K
FY21$67K
FY20$8.2M
FY19$6.8M
FY18$1.9M
FY17$167K
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Technology companies filing with the SEC
  • Harvard Bioscience
  • Technology median
−80%−60%−40%−20%0%20%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearHarvard BioscienceTechnology median
FY25−65.5%−2.4%
FY24−13.2%−5%
FY23−3%−6.7%
FY22−8.4%−4.4%
FY21−0.2%−1.7%
FY20−7.6%−3%
FY19−4%0%
FY18−2.4%0.8%
FY17−1.1%2%
FY16−4.1%2.3%
FY15−17.5%3.1%
FY142.2%2.9%
FY13−1.7%3.9%
FY122.1%3.9%
FY113.5%5.7%